| 11. |
Corticosteroids do not slow COPD progression |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1400,
2003,
Page 14-14
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 12. |
Oral arsenic trioxide is highly active in patients with relapsed acute promyelocytic leukaemia |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1400,
2003,
Page 15-15
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 13. |
Mycophenolate mofetil adjuvant therapy is effective and safe in patients with pemphigus vulgaris and pemphigus foliaceus |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1400,
2003,
Page 16-16
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 14. |
Insulin increases fibrinogen production in type 2 diabetes |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1400,
2003,
Page 17-17
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 15. |
Aripiprazole: novel antipsychotic may lessen risk of metabolic disorders |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1400,
2003,
Page 18-20
RM Poole,
Preview
|
|
摘要:
The prevalence of metabolic disorders, including diabetes mellitus, metabolic syndrome and hyperlipidaemia, is higher among patients with schizophrenia than in the general population. Although direct causality has yet to be proven, it is widely accepted that these conditions are associated with antipsychotic medication, particularly second-generation atypical antipsychotics. The development of metabolic disorders in patients receiving antipsychotic therapy was the subject of several presentations at the 156th Annual Meeting of the American Psychiatric Association (APA) [San Francisco, US; May 2003]. These studies assessed the prevalence of these conditions in patients receiving different antipsychotics, and their impact on healthcare resource utilisation. Interestingly, data from clinical studies suggested that aripiprazole ['Abilify'], a next-generation antipsychotic, was shown to be less likely to cause diabetes and hyperlipidaemia than other agents. This finding may have important implications for treatment practices, particularly in patients already at a high risk of developing metabolic disorders.
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 16. |
Meningococcal group C conjugate vaccine increases the risk of nephrotic syndrome relapse, |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1400,
2003,
Page 21-21
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 17. |
HRT and cardiovascular disease |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1400,
2003,
Page 22-22
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 18. |
Product Introductions |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1400,
2003,
Page 23-23
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
首页
